Interestingly, in breast cancer cell motility and metastatic potential are differentially enhanced depending on whether their mutations are localized at the helical or kinase domain. An overexpression of the helical domain through mutation E545K of PIK3CA produces a more severe metastatic phenotype compared to that of the kinase domain mutation H1047R [33]. Here, PIK3CA is linked to breast cancer.